Natixis Advisors LLC Has $4.16 Million Stock Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Natixis Advisors LLC trimmed its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 36.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 205,396 shares of the real estate investment trust's stock after selling 116,375 shares during the period. Natixis Advisors LLC's holdings in Healthpeak Properties were worth $4,163,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. State Street Corp bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the third quarter worth $403,898,000. Principal Financial Group Inc. boosted its holdings in shares of Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock valued at $367,575,000 after purchasing an additional 17,314,572 shares in the last quarter. Charles Schwab Investment Management Inc. bought a new position in shares of Healthpeak Properties in the 3rd quarter valued at $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Healthpeak Properties during the 3rd quarter worth $175,697,000. 93.57% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the company. Wedbush lowered their target price on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, February 14th. Robert W. Baird cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Tuesday, February 11th. Scotiabank reduced their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. StockNews.com upgraded Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Saturday. Finally, Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties has an average rating of "Moderate Buy" and a consensus price target of $23.92.

Remove Ads

Healthpeak Properties Trading Up 0.8 %

NYSE DOC traded up $0.16 during mid-day trading on Wednesday, reaching $20.32. 3,661,231 shares of the stock were exchanged, compared to its average volume of 4,775,881. The stock has a market cap of $14.21 billion, a P/E ratio of 58.04, a P/E/G ratio of 2.17 and a beta of 1.14. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a one year low of $17.70 and a one year high of $23.26. The stock has a 50 day simple moving average of $20.25 and a 200-day simple moving average of $21.14.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a $0.305 dividend. This is an increase from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 6.01%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.